Pharma Watch

Leading Pharma Leading Pharma

Challenged Pharma Challenged Pharma

FDA Approves First Drug Treatment of Peanut Allergy for Children

FDA Approves First Drug Treatment of Peanut Allergy for Children

The U.S. Food and Drug Administration approved Aimmune Therapeutics’ Palforzia [Peanut (Arachis hypogaea) Allergen Powder-dnfp] to mitigate allergic reactions, including anaphylaxis, that may occur with accidental exposure to peanuts.  Treatment may be initiated in...

subscribe

University at Buffalo
subscribe

Pin It on Pinterest